non-small cell lung cancer

J&J's lung cancer therapy succeeds in head-to-head study with AstraZeneca's drug
Reuters
Thu, 09/28/23 - 12:08 pm
JNJ
non-small cell lung cancer
AstraZeneca
Rybrevant
lazertinib
Tagrisso
Latest trial win further supports expanded use of Bristol Myers’ Opdivo in lung cancer
BioPharma Dive
Sun, 09/24/23 - 08:54 pm
Bristol Myers Squibb
Opdivo
non-small cell lung cancer
clinical trials
Could Gilead’s Trodelvy be the next TROP-2 therapy game-changer in NSCLC treatment?
Clinical Trials Arena
Fri, 09/22/23 - 12:00 pm
Gilead Sciences
Trodelvy
TROP-2
non-small cell lung cancer
Merck and Eisai's Keytruda-Lenvima combo chalks up 2 more losses, this time in non-small cell lung cancer
Fierce Pharma
Fri, 09/22/23 - 11:46 am
Merck
Eisai
Keytruda
Lenvima
melanoma
colorectal cancer
non-small cell lung cancer
AstraZeneca, Daiichi Sankyo show off ADC portfolio with safety top of mind
Fierce Biotech
Tue, 09/12/23 - 12:00 pm
AstraZeneca
Daiichi Sankyo
antibody-drug conjugate
non-small cell lung cancer
Dato-DXd
WCLC: Tagrisso's chemo combo shows edge, but AstraZeneca thinks monotherapy remains king in lung cancer
Fierce Pharma
Mon, 09/11/23 - 12:27 pm
AstraZeneca
Tagrisso
non-small cell lung cancer
Mirati’s Krazati remains effective in two-year follow-up of NSCLC patients
Clinical Trials Arena
Mon, 09/11/23 - 12:29 pm
Mirati Therapeutics
non-small cell lung cancer
Krazati
clinical trials
Roche posts interim TIGIT overall survival data after 'inadvertent disclosure,' sending stocks up
Fierce Biotech
Wed, 08/23/23 - 10:10 am
Roche
Tigit
clinical trials
lung cancer
non-small cell lung cancer
tiragolumab
FDA Grants Regular Approval of Gavreto for Metastatic NSCLC Subset
Cure Today
Wed, 08/9/23 - 10:42 pm
Genentech
Blueprint Medicines
Gavreto
non-small cell lung cancer
Eli Lilly meets primary endpoint in LIBRETTO-431 study for NSCLC
Clinical Trials Arena
Mon, 08/7/23 - 10:25 am
Eli Lilly
clinical trials
Retevmo
non-small cell lung cancer
Keytruda
Hummingbird begins Phase Ib trials of HMBD-001 in Australia
Clinical Trials Arena
Fri, 07/28/23 - 10:34 am
Hummingbird Bioscience
clinical trials
HMBD-001
squamous non-small cell lung carcinoma
non-small cell lung cancer
J&J touts Rybrevant win in newly diagnosed lung cancer, with key Tagrisso head-to-head readout up next
Fierce Pharma
Mon, 07/17/23 - 07:04 pm
JNJ
Rybrevant
non-small cell lung cancer
Takeda
Tagrisso
Iovance looks to advance its non-small cell lung cancer therapy
Clinical Trials Arena
Tue, 07/11/23 - 10:17 am
Iovance Biotherapeutics
clinical trials
tumor-infiltrating lymphocyte therapy
non-small cell lung cancer
lifileucel
AstraZeneca stock slides as pivotal lung cancer readout on Daiichi-partnered ADC spooks investors
Fierce Biotech
Mon, 07/3/23 - 11:40 am
AstraZeneca
Daiichi Sankyo
antibody-drug conjugate
Enhertu
clinical trials
non-small cell lung cancer
9 Highly Anticipated FDA Decisions in Second Half of 2023
BioSpace
Fri, 06/30/23 - 11:52 am
FDA
Eisai
Biogen
Leqembi
Alzheimer's disease
SAGE Therapeutics
zuranolone
postpartum depression
major depressive disorder
Roche
Tecentriq
non-small cell lung cancer
CRISPR Therapeutics
Bluebird Bio
lovo-cel
exa-cel
BrainStorm Cell Therapeutics
NurOwn
FDA approves Biostar’s Phase II/III plans with utidelone injectable for NSCLC
Clinical Trials Arena
Fri, 06/16/23 - 09:50 am
Biostar
FDA
utidelone
UTD1
non-small cell lung cancer
This Drug Candidate Could Be a Winner for Bristol Myers
Motley Fool
Mon, 06/12/23 - 10:18 am
Bristol Myers Squibb
repotrectinib
non-small cell lung cancer
metastatic small cell lung cancer
ASCO in Review: Oncologists See Practice-Changing, Affirming Data
BioSpace
Thu, 06/8/23 - 09:26 pm
ASCO 2023
oncologists
cancer
AstraZeneca
Tagrisso
non-small cell lung cancer
Novartis
Kisqali
breast cancer
Merck
Keytruda
Moderna Therapeutics
cancer vaccine
ASCO 2023 – early first-line lung cancer data mined for datopotamab gold
EP Vantage
Wed, 06/7/23 - 10:02 am
ASCO 2023
Daiichi Sankyo
AstraZeneca
datopotamab deruxtecan
non-small cell lung cancer
ASCO 2023: AstraZeneca’s PD-1/TIGIT shows promise in checkpoint-exposed NSCLC
Clinical Trials Arena
Tue, 06/6/23 - 10:06 am
ASCO 2023
AstraZeneca
clinical trials
non-small cell lung cancer
rilvegostomig

Pages